
Chemical and Pharmaceutical Bulletin p. 3206 - 3213 (1992)
Update date:2022-07-29
Topics:
Tanaka
Ito
Nishino
Motoyama
Takasugi
5-Alkyl-2-aryl-4-pyridylimidazoles were synthesized and tested in rat ex vivo platelet aggregation studies. Among these compounds, 2-(2-fluorophenyl)-5-methyl-4-(3-pyridyl)imidazole (25) was most potent, and showed 98% inhibition at a dose of 10 mg/kg (p.o.). 25 had inhibitory activity on cyclooxygenase, thromboxane A2 (TXA2) synthetase, and phosphodiesterase, and also showed inhibited KCl-induced contraction of rat aorta. All compounds have little acute toxicity and appear to be free of adverse effects on the stomach.
View MoreContact:+86-519-86339586,13584329896
Address:Changzhou Scientific and Education Park
Yueyang Hudex Pharmaceuticals Ltd.
Contact:0730-8748800
Address:Wujiang Bridge,Yueyang Economy & Technology Development Zone
ShangHai Ruiyi Medical Technology Co.,Ltd.
Contact:+86-21-54718086
Address:No951 Jianchuan RD,Minhang District
CHANGYI CITY FENGRUN FINE CHEMICAL CO.,LTD
website:http://www.fengrunhuagong.com
Contact:+86-536-7869976
Address:Changyi Coastal Economic Development Zone
Zibo Linzi Darong Fine Chemical Co., Ltd(expird)
Contact:86-532-67773200; 15689126900
Address:Qidu town,Linzi district,Zibo city,Shandong province,China
Doi:10.1021/ol006737a
(2001)Doi:10.1016/j.tet.2009.06.006
(2009)Doi:10.1007/s00706-013-1120-6
(2014)Doi:10.1002/anie.201913132
(2020)Doi:10.1021/ja01516a039
(1959)Doi:10.1021/cg2002628
(2011)